Figg, W. D., Chau, C. H., Madan, R. A., Gulley, J. L., Gao, R., Sissung, T. M., . . . Dahut, W. L. (2013). Phase II Study of Satraplatin and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Pharmacogenetic Assessment of Outcome and Toxicity.
Παραπομπή Chicago StyleFigg, William D., et al. Phase II Study of Satraplatin and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Pharmacogenetic Assessment of Outcome and Toxicity. 2013.
Παραπομπή MLAFigg, William D., et al. Phase II Study of Satraplatin and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Pharmacogenetic Assessment of Outcome and Toxicity. 2013.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.